BVXV Annual Cash & Cash Equivalents
$14.07 M
-$3.30 M-18.99%
31 December 2022
Summary:
As of February 5, 2025, BVXV annual cash & cash equivalents is $14.07 million, with the most recent change of -$3.30 million (-18.99%) on December 31, 2022. During the last 3 years, it has fallen by -$6.85 million (-32.74%).BVXV Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVXV Quarterly Cash And Cash Equivalents
$7.51 M
-$3.29 M-30.49%
30 June 2023
Summary:
As of February 5, 2025, BVXV quarterly cash and cash equivalents is $7.51 million, with the most recent change of -$3.29 million (-30.49%) on June 30, 2023. Over the past year, it has dropped by -$3.87 million (-34.02%).BVXV Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVXV Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.0% | -34.0% |
| 3 y3 years | -32.7% | -33.2% |
| 5 y5 years | -31.5% | -26.0% |
BVXV Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -32.7% | -65.5% |
BiondVax Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $7.51 M(-30.5%) |
| Mar 2023 | - | $10.80 M(-23.3%) |
| Dec 2022 | $14.07 M(-19.0%) | $14.07 M(+70.4%) |
| Sept 2022 | - | $8.26 M(-27.4%) |
| June 2022 | - | $11.38 M(-26.0%) |
| Mar 2022 | - | $15.37 M(-11.5%) |
| Dec 2021 | $17.37 M(+493.0%) | $17.37 M(+61.4%) |
| Sept 2021 | - | $10.77 M(-12.1%) |
| June 2021 | - | $12.25 M(-15.8%) |
| Mar 2021 | - | $14.55 M(+396.5%) |
| Dec 2020 | $2.93 M(-86.0%) | $2.93 M(-59.2%) |
| Sept 2020 | - | $7.18 M(-36.1%) |
| June 2020 | - | $11.24 M(-46.3%) |
| Dec 2019 | $20.93 M(+3.9%) | $20.93 M(-3.1%) |
| Sept 2019 | - | $21.60 M(+127.6%) |
| June 2019 | - | $9.49 M(-40.2%) |
| Mar 2019 | - | $15.86 M(-21.3%) |
| Dec 2018 | $20.15 M | $20.15 M(+37.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $14.67 M(+44.5%) |
| June 2018 | - | $10.15 M(-36.0%) |
| Mar 2018 | - | $15.85 M(-22.8%) |
| Dec 2017 | $20.54 M(+403.0%) | $20.54 M(-5.7%) |
| Sept 2017 | - | $21.78 M(+142.5%) |
| June 2017 | - | $8.98 M(+35.5%) |
| Mar 2017 | - | $6.63 M(+62.4%) |
| Dec 2016 | $4.08 M(-52.4%) | $4.08 M(+1.6%) |
| Sept 2016 | - | $4.02 M(+2.8%) |
| June 2016 | - | $3.91 M(-50.4%) |
| Mar 2016 | - | $7.89 M(-8.0%) |
| Dec 2015 | $8.57 M(+247.3%) | $8.57 M(-7.2%) |
| Sept 2015 | - | $9.24 M(-8.0%) |
| June 2015 | - | $10.04 M(+437.2%) |
| Mar 2015 | - | $1.87 M(-24.3%) |
| Dec 2014 | $2.47 M(-51.9%) | $2.47 M(-26.7%) |
| Sept 2014 | - | $3.37 M(-34.3%) |
| Dec 2013 | $5.13 M(+73.8%) | $5.13 M |
| Dec 2012 | $2.95 M | - |
FAQ
- What is BiondVax Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is BiondVax Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is BiondVax Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of BVXV is $14.07 M
What is the all time high annual cash & cash equivalents for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high annual cash & cash equivalents is $20.93 M
What is BiondVax Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, BVXV annual cash & cash equivalents has changed by -$3.30 M (-18.99%)
What is BiondVax Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BVXV is $7.51 M
What is the all time high quarterly cash and cash equivalents for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high quarterly cash and cash equivalents is $21.78 M
What is BiondVax Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, BVXV quarterly cash and cash equivalents has changed by -$3.87 M (-34.02%)